Healthcare provider profile · identity verified

Robert A Wolfson, MD

Internal Medicine · MOUNT KISCO, NY · NPI 1134175359

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	778	212
Losartan Potassium	Losartan Potassium	356	101
Rosuvastatin Calcium	Rosuvastatin Calcium	337	103
Amlodipine Besylate	Amlodipine Besylate	298	87
Levothyroxine Sodium	Levothyroxine Sodium	256	70
Zolpidem Tartrate	Zolpidem Tartrate	246	44
Metoprolol Succinate	Metoprolol Succinate	228	67
Pantoprazole Sodium	Pantoprazole Sodium	181	55
Omeprazole	Omeprazole	154	51
Allopurinol	Allopurinol	143	40
Alprazolam	Alprazolam	134	36
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	121	36
Hydrochlorothiazide	Hydrochlorothiazide	117	33
Eliquis	Apixaban	115	30
Sertraline Hcl	Sertraline Hcl	101	32
Lorazepam	Lorazepam	100	22
Metformin Hcl Er	Metformin Hcl	97	27
Tamsulosin Hcl	Tamsulosin Hcl	93	26
Simvastatin	Simvastatin	92	27
Metformin Hcl	Metformin Hcl	91	30
Lisinopril	Lisinopril	89	26
Mirtazapine	Mirtazapine	89	21
Furosemide	Furosemide	85	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	81	67
Ozempic	Semaglutide	81	19
Jardiance	Empagliflozin	77	17
Synthroid	Levothyroxine Sodium	77	21
Prednisone	Prednisone	76	41
Albuterol Sulfate Hfa	Albuterol Sulfate	73	37
Glipizide Er	Glipizide	72	22
Bupropion Xl	Bupropion Hcl	71	21
Gabapentin	Gabapentin	70	24
Diazepam	Diazepam	67	11
Venlafaxine Hcl Er	Venlafaxine Hcl	62	14
Ezetimibe	Ezetimibe	61	21
Famotidine	Famotidine	60	14
Valsartan	Valsartan	59	15
Mounjaro	Tirzepatide	56	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	56	12
Pravastatin Sodium	Pravastatin Sodium	56	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	56	15
Escitalopram Oxalate	Escitalopram Oxalate	53	17
Xarelto	Rivaroxaban	53	13
Metoprolol Tartrate	Metoprolol Tartrate	52	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	51	13
Spironolactone	Spironolactone	49	14
Azithromycin	Azithromycin	48	35
Atenolol	Atenolol	47	12
Clopidogrel	Clopidogrel Bisulfate	47	13
Duloxetine Hcl	Duloxetine Hcl	47	12
Alendronate Sodium	Alendronate Sodium	46	13
Ipratropium Bromide	Ipratropium Bromide	45	20
Clonazepam	Clonazepam	41	11
Valacyclovir	Valacyclovir Hcl	41	20
Montelukast Sodium	Montelukast Sodium	39	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	39	39
Pioglitazone Hcl	Pioglitazone Hcl	39	11
Sildenafil Citrate	Sildenafil Citrate	39	11
Telmisartan	Telmisartan	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	13
Ondansetron Odt	Ondansetron	36	suppressed
Celecoxib	Celecoxib	34	12
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Finasteride	Finasteride	32	11
Meloxicam	Meloxicam	32	13
Doxazosin Mesylate	Doxazosin Mesylate	30	11
Ketoconazole	Ketoconazole	29	13
Nicotrol Ns	Nicotine	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	24
Minoxidil	Minoxidil	28	suppressed
Potassium Chloride	Potassium Chloride	28	suppressed
Irbesartan	Irbesartan	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Cefuroxime	Cefuroxime Axetil	23	19
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Naproxen	Naproxen	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Warfarin Sodium	Warfarin Sodium	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	18
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Ramipril	Ramipril	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Testosterone	Testosterone	14	suppressed
Digoxin	Digoxin	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Linzess	Linaclotide	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error